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was normal. In contrast, stabilization of β-catenin in cholangiocyte precursors
perturbed duct development and cholangiocyte differentiation. We conclude that
β-catenin is dispensable for biliary development but that its activity must be
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a b s t r a c t
Beta-catenin is known to play stage- and cell-speciﬁc functions during liver development. However, its role
in development of bile ducts has not yet been addressed. Here we used stage-speciﬁc in vivo gain- and
loss-of-function approaches, as well as lineage tracing experiments in the mouse, to ﬁrst demonstrate that
β-catenin is dispensable for differentiation of liver precursor cells (hepatoblasts) to cholangiocyte pre-
cursors. Second, when β-catenin was depleted in the latter, maturation of cholangiocytes, bile duct mor-
phogenesis and differentiation of periportal hepatocytes from cholangiocyte precursors was normal. In
contrast, stabilization of β-catenin in cholangiocyte precursors perturbed duct development and cho-
langiocyte differentiation. We conclude that β-catenin is dispensable for biliary development but that its
activity must be kept within tight limits. Our work is expected to signiﬁcantly impact on in vitro differ-
entiation of stem cells to cholangiocytes for toxicology studies and disease modeling.
& 2016 International Society of Differentiation. Published by Elsevier B.V. All rights reserved.
1. Introduction
Wnt-β-catenin signaling exerts distinct functions during liver
development (Lade and Monga, 2011). Prior to liver formation,
namely when the endoderm is being patterned along its antero-
posterior axis, Wnt-β-catenin signaling must be repressed in the
foregut endoderm to allow expression of transcription factors in-
volved in early liver development (Goessling et al., 2008; Li et al.,
2008; McLin et al., 2007). Beyond the stage of endoderm pat-
terning and during the earliest stages of hepatic morphogenesis,
Wnt signaling no longer represses, but instead stimulates liver
speciﬁcation and growth (Goessling et al., 2008; McLin et al.,
2007; Micsenyi et al., 2004; Ober et al., 2006; Suksaweang et al.,
2004). Later, when the liver epithelial cells consist of hepatoblasts,
β-catenin depletion is associated with impaired proliferation, in-
creased apoptosis, and deﬁcient differentiation of the hepatoblasts
(Tan et al., 2008). However, depletion of adenomatous polyposis
coli (APC) in hepatoblasts, which stabilizes β-catenin and increases
its activity, unexpectedly exerts similar effects as β-catenin
depletion: lack of APC impairs proliferation of hepatoblasts and
differentiation to hepatocytes (Decaens et al., 2008). The dis-
crepancy might result from time-dependent effects of β-catenin.
Indeed, β-catenin was depleted starting at E9.5, while APC was
depleted starting at E11.5. This raises the question of stage-speciﬁc
effects of β-catenin.
Regarding differentiation of hepatoblasts to the cholangiocyte
lineage there is evidence from both loss-of-function and gain-of-
function experiments with ex vivo explants that Wnt-β-catenin
signaling promotes biliary differentiation (Hussain et al., 2004;
Monga et al., 2003). Consistent with this, in vivo activation or in-
hibition of β-catenin stimulated biliary differentiation of hepato-
blasts (Decaens et al., 2008; Tan et al., 2008). At later stages of
biliary development, cholangiocyte precursors that are organized
as a ductal plate strongly express β-catenin, of which the active
non-phosphorylated form is transiently detected around E17.5
(Decaens et al., 2008). However, how β-catenin impacts on ma-
turation of the cholangiocyte precursors and on bile duct mor-
phogenesis has not yet been addressed. This issue is now gaining
new and signiﬁcant importance. Indeed, recent experiments in
which stem cells are programmed in vitro to cholangiocytes have
recently met with promising success, thereby providing innovative
tools for pharmacological studies and biliary disease modeling
(Dianat et al., 2014; Ogawa et al., 2015; Sampaziotis et al., 2015).
Still, stem cell-derived cholangiocytes are immature, demonstrat-
ing the need to fully understand developmental mechanisms
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driving bile duct development in order to allow optimal re-
capitulation of developmental processes in cultured stem cells.
Here we investigate the in vivo function of β-catenin at several
stages of hepatoblast and cholangiocyte differentiation, and bile
duct morphogenesis. We show that β-catenin is dispensable for
differentiation of hepatoblasts to the biliary lineage, and for de-
velopment of bile ducts from cholangiocyte precursors, but that
overexpression of β-catenin is detrimental for biliary differentia-
tion and morphogenesis.
2. Materials and methods
2.1. Animals
All experimental procedures using animals were approved by
the University's Animal Ethics Committee and were conducted in
compliance with the animal welfare regulations of Belgium. Ani-
mals received humane care according to the criteria outlined in
the “Guide for the Care and Use of Laboratory Animals” prepared
by the National Academy of Sciences and published by the Na-
tional Institutes of Health (NIH publication 86–23 revised 1985).
Sox9-CreERT2 (Kopp et al., 2011), Alfp-Cre (Kellendonk et al.,
2000), Ctnnb1lox (ﬂoxed exons 2–6) (Brault et al., 2001),
Ctnnb1lox(ex3) (ﬂoxed exon 3) (Harada et al., 1999), Apclox (Colnot
et al., 2004) and ROSA26ReYFP (Srinivas et al., 2001) mice were
maintained in a mixed Bl6/CD1 background. Sections from
Foxa3-Cre/βCatlox/lox embryonic livers were from the study of Tan
et al. (2008).
For induction of Sox9-CreER activity, tamoxifen (Sigma (T5648),
Bornem, Belgium) was dissolved in corn oil (Sigma (C8267), Bor-
nem, Belgium) at a concentration of 30 mg/ml and in-
traperitoneally injected into E14.5 pregnant mothers at 100 mg/kg
body weight. Embryos were collected at the indicated times.
Quantiﬁcation of recombination efﬁciency induced by Sox9CreER
in Sox9-CreER/βCatKO/Rosa26ReYFP livers was performed by mea-
suring the percentage of Sox9þ cells that express YFP
(YFPþ;Sox9þ/[YFPþ;Sox9þþYFP;Sox9þ])*100. At each devel-
opmental stage, cells of 6 periportal areas were counted per liver
and 2 livers were considered per stage. The total number of
counted SOX9þ cells was 996 (E15.5), 925 (E16.5) and 982 (E17.5).
2.2. Immunoﬂuorescence
Mouse liver tissue samples were formalin-ﬁxed and parafﬁn-
embedded. Five μm-thick sections were stained as described
(Carpentier et al., 2011) using antibodies and conditions listed in
Supplementary Table 1. Pictures were taken with an Axiovert 200
ﬂuorescent microscope using AxioVision system or a Cell Observer
Spinning Disk confocal microscope (Carl Zeiss, Zaventem,
Belgium).
Quantiﬁcation of proliferation was performed by measuring the
percentage of Sox9þ/βcatnormal (wild-type, n¼3) and
Sox9þ/βcathigh cells (Sox9-CreER/Apclox/lox, n¼3; Sox9-CreER/
beta-catlox(exon 3)lox, n¼2) that express phosphohistone H3. The
number of cells counted was: 879 Sox9þ/βcatnormal cells in wild-
type livers, 850 Sox9þ/βcathigh cells in Sox9-CreER/Apclox/lox livers,
and 812 Sox9þ/βcathigh cells in Sox9-CreER/βcatlox(exon 3)lox livers.
2.3. Quantitative real-time PCR analysis
RNA from total liver RNA was extracted from liver using Trizol
reagents (Invitrogen, Carlsbad, CA) 2 μg was reverse-transcribed
with random hexamers using Moloney Murine Leukemia Virus
reverse transcriptase (Invitrogen, Carlsbad, CA). Real-time quanti-
tative PCR was performed by using Kapa SYBR FAST qPCR Master
Mix (KapaBiosystems). Primers are listed in Supplementary Ta-
ble 2. Microsoft Excel was used to calculate standard deviations
and evaluate the statistical signiﬁcance of the results (two-tailed
Student's t test). P values o0.05 or lower were considered sta-
tistically signiﬁcant. Gene expression was measured in four wild-
type or four mutant embryonic livers. Data were normalized for
GAPDH expression.
3. Results
3.1. Beta-catenin is dispensable for differentiation of hepatoblasts to
cholangiocyte precursors
Intrahepatic cholangiocyte precursors derive from hepato-
blasts, and the onset of biliary differentiation is marked by ex-
pression of SRY-related HMG box transcription factor 9 (Sox9) at
E11.5 (Antoniou et al., 2009). The number of Sox9þ cholangiocyte
precursors progressively increases from E11.5 to E15.5, and around
E15.5 they line up around the branches of the portal vein to form a
ductal plate. To address the role of β-catenin during the hepato-
blast-to-cholangiocyte precursor transition, we generated em-
bryos that have ﬂoxed alleles of β-catenin (Ctnnb1lox/lox) and bear
the Albumin-α fetoprotein-Cre (Alfp-Cre) transgene to inactivate
β-catenin in the hepatoblasts. Alfp-Cre drives expression of Cre
recombinase in hepatoblasts starting at E10.5 (Kellendonk et al.,
2000), and time-course analysis revealed that β-catenin expres-
sion was lost by E12.5 in almost all liver epithelial cells of
Alfp-Cre/Ctnnb1lox/lox embryos (hereafter called Alfp-Cre/βCatKO)
(Fig. 1A). The mesenchyme and blood vessels, which do not ex-
press Alfp-Cre, retained normal β-catenin levels (Fig. 1A). The
regular cord-like organization of hepatoblasts was lost and several
epithelial cells throughout the parenchyma were E-cadherinþ
HNF4α , which reﬂects deﬁcient differentiation toward the he-
patocyte lineage (Fig. 1A). These data were consistent with pre-
vious observations (Tan et al., 2008).
Alfp-Cre/βCatKO embryos were present in a Mendelian ratio
until E17.5 but none survived beyond birth (data not shown).
Analysis of the livers at E17.5 further showed perturbed liver ar-
chitecture (Fig. 1A). Consistent with previous reports (Tan et al.,
2008), hepatocyte differentiation was inhibited as shown by the
low levels of Albumin and Transthyretin (Fig. 1B). We also detected
Sox9þ biliary cells in the ductal plate and developing ducts of
Alfp-Cre/βCatKO livers, and these cells did not express β-catenin.
They expressed the transcription factor Hepatocyte Nuclear Factor
(HNF)1β but not the hepatocyte marker HNF4α (Fig. 1A), indicat-
ing that they were correctly speciﬁed and differentiated. At E17.5
polarity markers Osteopontin (OPN)) and Zonula Occludens-1
(ZO1) were expressed at the apical pole of these ducts, indicating
that β-catenin-deﬁcient biliary cells were well-polarized (Fig. 1A).
qRT-PCR analyses at E17.5 revealed that the expression of biliary
markers was normal or increased (Fig. 1B). Interestingly, markers
of Wnt-β-catenin signaling were also normal or increased. Gam-
ma-catenin expression was unaffected, and may contribute to
compensate for the loss of β-catenin (Wickline et al., 2011),
thereby potentially explaining why several markers of the Wnt-β-
catenin pathway remain in the normal range. Wnt5a is increased,
revealing a negative feedback between β-catenin and Wnt5a. The
morphology of the ductal plate and developing ducts was abnor-
mal: the number of luminal duct-like structures was increased and
the latter were often irregularly shaped. Sox9þ β-catenin cho-
langiocytes were detected at the hilum, center and periphery of
the liver lobes in Alfp-Cre/βCatKO livers at E17.5, indicating that
differentiation of biliary cells along the hilum-to-periphery axis
occurs independently of β-catenin (Supplementary Fig. 1). We
concluded that β-catenin is dispensable for differentiation of
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hepatoblasts to the cholangiocyte lineage but that β-catenin in-
activation in hepatoblasts induces subsequent perturbed duct
morphogenesis, most likely as a result of perturbed liver
architecture.
The above results contrasted with previous in vivo β-catenin
depletion experiments which instead suggested that β-catenin
was required for biliary differentiation (Tan et al., 2008). However,
in the present work, β-catenin was depleted by Alfp-Cre around
E12–E13, while Tan and coworkers studied Foxa3-Cre/βCatKO li-
vers in which β-catenin was suppressed earlier, namely at E9.5. At
least a subset of Sox9þ β-catenin cholangiocyte precursors in
Alfp-Cre/βCatKO livers could have been speciﬁed before β-catenin
was completely suppressed. Alternatively, the two-day window
that differs among the two studies might reveal a restricted time
period during which β-catenin is necessary to prime hepatoblasts
for subsequent β-catenin-independent biliary speciﬁcation. To
clarify the issue, we reanalyzed biliary differentiation in
Foxa3-Cre/βCatKO embryonic livers. These livers showed the pre-
viously described parenchymal disorganization, but to our sur-
prise, biliary cells were detected: Sox9þ β-catenin cells were
present and formed duct-like structures that expressed HNF1β
and OPN, but not HNF4α, which is indicative of their biliary ma-
turation (Fig. 2). Therefore, we conclude that β-catenin is not re-
quired to initiate differentiation of biliary cells from hepatoblasts.
3.2. Beta-catenin expression in cholangiocyte precursors is dis-
pensable for bile duct morphogenesis
The study of Alfp-Cre/βCatKO and Foxa3-Cre/βCatKO livers does
not enable us to speciﬁcally address the role of β-catenin in duct
morphogenesis. Indeed, this process starts around E15.5 (Antoniou
et al., 2009; Takashima et al., 2015), and the morphogenic
anomalies in Alfp-Cre/βCatKO and Foxa3-Cre/βCatKO may result
from the globally perturbed organization of the liver parenchyma.
Therefore, we inactivated β-catenin speciﬁcally in the ductal plate
by generating embryos that have ﬂoxed alleles of β-catenin
(Ctnnb1lox/lox) and bear the tamoxifen-inducible Sox9-CreER
transgene (Kopp et al., 2012). An additional ROSA26ReYFP reporter
allele was included to allow tracing of the cells in which CreER has
been activated.
A single intraperitoneal injection of tamoxifen in pregnant fe-
males at E14.5 resulted in near total recombination efﬁciency in
the ductal plate after 48 h. Indeed, in Sox9-CreER/
βCatKO/Rosa26ReYFP embryos, β-catenin was still expressed in
most Sox9þ cells at E15.5, but it was no longer detected in the vast
majority of Sox9þ cells at E16.5 and E17.5 (Fig. 3A). Sox9þ eYFPþ
cells were devoid of β-catenin, as expected. Analysis of livers at
E18.5 revealed that β-catenin-deﬁcient cholangiocytes were phe-
notypically indistinguishable from their wild-type counterparts
(Fig. 3B): the differentiation markers HNF6, HNF1β and Sox9, were
expressed at normal levels, while the hepatocyte marker HNF4α
was absent as expected. Apical polarity markers OPN, Mucin-1
(Muc1) and Zonula occludens-1 (ZO1), as well as the basolateral
and basal markers E-cadherin and αSMA were also expressed
normally (Fig. 3B).
3.3. Beta-catenin is not required for cell fate determination of cho-
langiocyte precurors
Cholangiocyte precursors in the ductal plate were shown ear-
lier to give rise to the adult biliary tract but also to a subset of
periportal hepatocytes (Carpentier et al., 2011). To verify if this cell
fate allocation depends on β-catenin, we injected tamoxifen in
mothers bearing Sox9-CreER/βCatKO/Rosa26ReYFP embryos to label
the cholangiocyte precursors, and analyzed the livers of the off-
spring at postnatal day (P) 20. Mothers injected with tamoxifen
devoured their pups immediately after delivery (data not shown).
To circumvent that problem we obtained lineage-traced
Sox9-CreER/βCatKO/Rosa26ReYFP pups by cesarian birth at E19.0.
These pups were adopted by foster mothers and survived with no
overt phenotype. Analysis of Sox9-CreER/βCatKO/Rosa26ReYFP li-
vers at P20 revealed that β-catenin-deﬁcient bile ducts were
Fig. 1. β-catenin controls hepatic morphogenesis but is not required for differentiation of hepatoblasts to the biliary lineage. (A) Embryos with inactivation of β-catenin
starting around E12.5 (Alfp-Cre/βCatKO) showed perturbed liver architecture, abnormal differentiation of hepatocytes, and ductal plates composed of well-differentiated
cholangiocytes organized around abnormally shaped luminal structures. (B) qRT-PCR analysis of E17.5 Alfp-Cre/βCatKO livers showed that cholangiocyte markers were
normal or upregulated while hepatocyte markers were normal or downregulated. Data are means 7SD, n¼4, ***po0.001, **po0.01, *po0.05. Alb, albumin; APC, ade-
nomatous polyposis coli; Bicc1, bicaudal-c1; βCat, β-catenin; dp, ductal plate; Ecad, E-cadherin; γCat, γ-catenin; Opn, osteopontin; pv, portal vein; Ttr, transthyretin; ZO-1,
zona occludens-1; *, lumen of ductal structure; scale bar, 100 μm.
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normal (Fig. 4). β-catenin-deﬁcient cholangiocytes expressed the
biliary marker Sox9, and cytokeratin 19 (CK19) and did not express
the hepatocyte markers HNF4α, carbamoyl phosphate synthetase-
1 (CPS1) or glutamine synthetase (GS) (Fig. 4; Supplementary
Fig. 2). Importantly, a subset of periportal hepatocytes were YFPþ
(Fig. 4), indicating that they derived from the β-catenin-deﬁcient
ductal plate, and demonstrating that fate determination of cho-
langiocyte precursors does not critically depend on β-catenin.
3.4. Overexpression of β-catenin in developing cholangiocytes per-
turbs bile duct morphogenesis and cholangiocyte differentiation
Beta-catenin is not required for bile duct development, but we
next wished to determine if it can promote bile duct morpho-
genesis. To address this question, embryos from two transgenic
lines with activation of β-catenin were investigated, namely em-
bryos that have inducible and bile duct-speciﬁc inactivation of APC
(Sox9-CreER/Apclox/lox), or deletion of the third exon of the β-ca-
tenin gene (Sox9-CreER/Ctnnb1lox(ex3)/lox(ex3)). Removal of this
exon prevents phosphorylation-induced degradation of β-catenin
(Harada et al., 1999). Inactivation of APC or removal of β-catenin
exon 3 was induced by injection of tamoxifen at E14.5, followed by
phenotypic analysis at E18.5.
Compared to their wild-type littermates, mutant embryos
showed striking bile duct dysplasia (Fig. 5; Supplementary Fig. 2). We
observed patches of pseudo-tubular structures with strong induction
of β-catenin. Beta-catenin-overexpressing cells were Sox9þ , CK19þ ,
HNF4α , as expected for biliary cells. However, these cells failed to
express HNF1β, Osteopontin or Mucin-1, indicating that differentia-
tion and polarity were affected. Embryos with APC inactivation
showed the same phenotype as those with deletion of β-catenin's
exon 3, demonstrating that this phenotype is indeed caused by ac-
tivation of β-catenin. Tamoxifen treatment at E14.5 induces Sox9-
CreER activity around E15.5 (Carpentier et al., 2011), a stage where
HNF1β, Muc1 and Opn are already expressed in developing ductal
structures; this implies that β-catenin not only blocks cholangiocyte
maturation but also reverts their phenotype to a less well differ-
entiated state. Beta-catenin did not impact on proliferation: expres-
sion of phosphohistone H3 was similar in Sox9þ/βcatnormal (wild-
type) and Sox9þ/βcathigh (Sox9-CreER/Apclox/lox and
Sox9-CreER/beta-catlox(exon 3)lox) cells (Fig. 5B). We concluded that β-
catenin is dispensable for bile duct morphogenesis but that accurate
regulation of β-catenin concentration and function is necessary for
proper biliary development.
4. Discussion
Beta-catenin plays essential roles in adult and developing liver
(Gougelet and Colnot, 2012; Lade and Monga, 2011; Monga, 2015;
Fig. 2. Early deletion of β-catenin in developing liver impairs hepatic morphogenesis but is compatible with biliary differentiation. Embryos with inactivation of β-catenin
starting around E10.5 (Foxa3-Cre/βCatKO) showed perturbed liver architecture and differentiation of hepatocytes at E17.5; the number of HNF4αþ cells (arrowheads) was
reduced. Biliary cells expressed the expected biliary markers but formed an increased number or irregularly-shaped luminal structures. βCat, β-catenin; Ecad, E-cadherin; hd,
hepatic duct; OPN, osteopontin; pv, portal vein; *, lumen of ductal structure; scale bar, 100 μm.
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Torre et al., 2011). During liver development, cell- and stage-spe-
ciﬁc effects have been identiﬁed, but β-catenin function has not
been addressed during bile duct morphogenesis. Here, using gain-
and loss-of-function mouse models we show that β-catenin is
dispensable for differentiation of hepatoblasts to the biliary line-
age and for bile duct morphogenesis, but that overexpression of β-
catenin is detrimental for duct morphogenesis.
Canonical Wnt-β-catenin signaling is tightly dependent on the
cellular context. An appropriate balance between time- and tissue-
speciﬁc regulators (ligands, ligand traps, receptors) that turn sig-
naling on or off determines the eventual level of signaling activity
during early liver development (McLin et al., 2007). Evaluating
such balance at the experimental level is exceedingly difﬁcult
considering the number of Wnt ligands and receptors functional in
Fig. 3. Beta-catenin is dispensable for bile duct morphogenesis. (A) After injection of tamoxifen at E14.5, inactivation of β-catenin in developing ducts
(Sox9-CreER/βCatKO/Rosa26ReYFP) was detectable at E15.5 and near complete at E16.5 and E17.5. Recombination efﬁciency, expressed as percentage of Sox9þ cells that
express YFP ((YFPþ;Sox9þ/[YFPþ;Sox9þþYFP;Sox9þ])*100) is indicated. (B) Inactivation of β-catenin in developing bile ducts was associated with normal cholangiocyte
differentiation and polarity, and normal development of bile ducts at E18.5. αSMA, α smooth muscle actin; βCat, β-catenin; dp, ductal plate; Muc1, mucin-1; OPN, osteo-
pontin; pv, portal vein; ZO-1, zona occludens-1; *, lumen of ductal structure; scale bar, 100 μm.
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Fig. 4. Beta-catenin is dispensable for cell fate determination of cholangiocyte precurors. Lineage tracing of the cholangiocyte precusors labeled at E14.5
(Sox9-CreER/βCatKO/Rosa26ReYFP) showed that these cells generate bile ducts and periportal hepatocytes in postnatal livers, in the presence
(Sox9-CreER/βCatWT/Rosa26ReYFP) or absence (Sox9-CreER/βCatKO/Rosa26ReYFP) of β-catenin. Periportal hepatocytes derived from the wild-type or β-catenin-deﬁcient
cholangiocyte precursors expressed carbamoyl-phosphate-synthetase-1 (CPS1), but not glutamine synthetase (GS). βCat, β-catenin; cv, central vein; Ecad, E-cadherin; pv,
portal vein; YFP, yellow ﬂuorescent protein; *, lumen of bile duct, scale bar (200 μm).
Fig. 5. Beta-catenin overexpression in developing bile ducts induces biliary dysplasia and perturbs cholangiocyte differentiation and polarity. (A) Beta-catenin was induced
by inactivation of APC or deletion of exon 3 from the β-catenin gene (Ctnnb1) in developing bile ducts using tamoxifen-inducible Sox9-CreER. Tamoxifen was injected at
E14.5 and embryos were collected at E18.5, prior immunostaing analysis with the indicated markers. (B) Proliferation was quantiﬁed by measuring the percentage (7SD) of
Sox9þ/βcatnormal (wild-type) and Sox9þ/βcathigh cells (Sox9-CreER/Apclox/lox and Sox9-CreER/beta-catlox(exon 3)lox) that express phosphohistone H3 (see materials and
methods). βCat, β-catenin; Muc1, mucin-1; OPN, osteopontin; pv, portal vein; *, lumen of ductal structure; scale bar, 100 μm.
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liver (Zeng et al., 2007). Cross-talks between Wnt-β-catenin and
other pathways add another layer of complexity, as illustrated by
the modulation of Wnt signaling in liver by Fibroblast Growth
Factor 10 (Berg et al., 2007; Shin et al., 2012). In addition, several
processes are controlled by an equilibrium between canonical and
non-canonical Wnt signaling, as shown by the non-canonical
Wnt5a-dependent inhibition of β-catenin that results in hepato-
cyte proliferation arrest at the end of liver regeneration (Yang
et al., 2015). Along the same lines, the Wnt5a-calcium/calmodulin-
dependent protein kinase II pathway has been shown to repress
biliary differentiation (Kiyohashi et al., 2013), while Wnt-β-catenin
signaling is usually considered to promote biliary differentiation.
The complex regulation of Wnt-β-catenin signaling outlined
above is susceptible to generate conﬂicting results when studying
the function of signaling mediators. Indeed, despite that β-catenin
depletion is expected to generate an opposite phenotype to that
resulting from β-catenin stabilization by APC depletion, both ap-
proaches generated similar effects on hepatoblast proliferation
and survival, and on hepatocyte differentiation (Decaens et al.,
2008; Tan et al., 2008). This apparent discrepancy might result
from the fact that β-catenin was partially depleted starting at E9.5
(Tan et al., 2008) while APC was inactivated by E11.5 (Decaens
et al., 2008), potentially revealing time-dependent effects of β-
catenin in hepatoblasts. However, our present results combined
with those of Decaens and co-workers show that inactivation or
stabilization of β-catenin at the same developmental stage simi-
larly perturb liver architecture and hepatocyte differentiation.
Therefore, time-dependent effects of β-catenin are unlikely to
explain the discrepancy. Consequently, we suggest that compen-
satory mechanism appearing in conditions of β-catenin depletion
might not have a counterpart when β-catenin is stabilized. In this
context, β-catenin depletion is known to be associated with
compensatory effects of γ-catenin (Wickline et al., 2011), a gene
whose expression was maintained in β-catenin-deﬁcient embronic
liver. The normal expression of γ-catenin in the absence of β-ca-
tenin may contribute to maintain the expression of β-catenin
target genes, as observed here. Along the same lines, APC-in-
dependent effects of β-catenin have been described (Xiao et al.,
2003), leading to the possibility that APC depletion may lead to a
phenotype that is not a mirror image of β-catenin depletion.
Surprisingly, β-catenin-deﬁcient livers develop cholangiocytes but
express higher levels of Wnt5a, a repressor of biliary differentia-
tion. Our interpretation is that the rise in Wnt5a is not sufﬁcient to
inhibit differentiation.
Earlier work, either by APC depletion or by β-catenin in-
activation, indicated that β-catenin is both necessary and sufﬁcient
to promote differentiation of hepatoblasts toward a biliary phe-
notype (Decaens et al., 2008; Hussain et al., 2004; Monga et al.,
2003; Tan et al., 2008). Here we update this conclusion by de-
monstrating that β-catenin is actually not required for biliary
differentiation. Foxa3-Cre dependent deletion of β-catenin in de-
veloping liver led to a substantial distortion of hepatic archi-
tecture, which led to the previous deductions of an important and
primary role of β-catenin in early biliary development. However,
with more timely markers of biliary development, such as Sox9
and OPN, we were able to directly and more conclusively show
that β-catenin is dispensable for biliary differention.
Our present work investigates for the ﬁrst time the develop-
mental role of β-catenin beyond the stage of hepatoblast-biliary
precursor transition, namely during bile duct morphogenesis and
cholangiocyte maturation. Using an in vivo loss-of-function ap-
proach, we show that β-catenin is not required for cholangiocyte
maturation and duct formation. It remains an open-ended ques-
tion though, if loss of β-catenin in Sox9þ cells could be com-
pensated by another mechanisms such as γ-catenin and future
studies would be necessary to address that directly. In parallel,
using two independent gain-of-function approaches we demon-
strated that excessive β-catenin activity in developing ducts sti-
mulates biliary development. However, the latter was character-
ized by aberrant morphology of ducts and perturbed differentia-
tion of the cholangiocytes. We note that excessive β-catenin ac-
tivity in hepatoblasts stimulated cholangiocyte differentiation, but
in that case also, differentiation was abnormal, as illustrated by
low HNF1β levels (Decaens et al., 2008).
We conclude that β-catenin is dispensable for differentiation of
hepatoblasts to cholangiocyte precursors, but that β-catenin ac-
tivity must be kept within tight limits to allow normal maturation
of the precursors to mature cholangiocytes, and to permit normal
bile duct formation. These data need to be taken into account
when programming stem cells in vitro to cholangiocytes for tox-
icology studies and disease modeling experiments.
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